2014 Annual Meeting | 7HC.007 - Neuro-oncology: Primary Brain Tumors

Date Friday 05/02/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Jaishri Blakeley, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the common presenting signs and symptoms and the current recommendations for the diagnosis and treatment of primary brain tumors in adults. This includes identifying most appropriate diagnostic techniques, incorporating prognostic and predictive factors into treatment decisions, and current recommendations for systemic therapies. Participants should gain an evidence base for the management of seizures, venous thrombosis, and cognitive symptoms during and after brain tumor treatment, and learn strategies to enhance quality of life for patients with long-term complications and sequelae of tumor therapy.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
01:00 PM - 01:05 PM		Introduction Jaishri Blakeley, MD, FAAN
01:05 PM - 01:35 PM		Taming the Beast: Managing Gliomas Jaishri Blakeley, MD, FAAN
01:35 PM - 02:05 PM		Practical Management of Primary CNS Lymphoma Erin M. Dunbar, MD
02:05 PM - 02:35 PM		When Benign Is Not Benign—Meningiomas and Other “Benign” Brain Tumors Marc Chamberlain, MD
02:35 PM - 02:45 PM		Break
02:45 PM - 03:15 PM		Calling a Friend: When Does Surgery Help?
03:15 PM - 03:45 PM		Managing the Complications of Primary Brain Tumors Scott R. Plotkin, MD, PhD, FAAN
03:45 PM - 03:55 PM		Break
03:55 PM - 05:00 PM		Multi-disciplinary Tumor Board

Faculty Disclosures
Jaishri Blakeley, MD, FAAN	Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Marc Chamberlain, MD	No disclosure on file
Erin M. Dunbar, MD	Dr. Dunbar has nothing to disclose.
Scott R. Plotkin, MD, PhD, FAAN	Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file